Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Ansprenger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|February 1, 2019
Christian Ansprenger, Emanuel Burri
Therapeutische Umschau. Revue Therapeutique|November 30, 2021
[Interventional endoscopy in hepatico-pancreatico-biliary disease]Emanuel Burri, Christian Ansprenger
Clinical Immunology (Orlando, Fla.)|May 29, 2020
Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DC<sub>leu</sub>)Christian Ansprenger, Daniel Christoph Amberger, Helga Maria Schmetzer
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2014
Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cellsValentin Vogt, Julia Schick, Christian Ansprenger, et al.
Cellular Immunology|March 28, 2018
Paramunity-inducing Factors (PINDs) in dendritic cell (DC) cultures lead to impaired antileukemic functionality of DC-stimulated T-cellsChristian Ansprenger, Valentin Vogt, Julia Schick, et al.
Cellular Immunology|July 29, 2010
Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potentialAnja Liepert, Christine Grabrucker, Andreas Kremser, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2019
Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic ReactionsAnnika Hirn Lopez, Diana Deen, Zuzanna Fischer, et al.
Cancers|March 14, 2026
Modulation of Leukemic Blasts into Dendritic Cells (DC<sub>leu</sub>) and Their Role in Predicting Survival in Patients with AML and MDSDaniel Christoph Amberger, Zuzana Fischer, Diana Deen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|February 1, 2019
Christian Ansprenger, Emanuel Burri
Therapeutische Umschau. Revue Therapeutique|November 30, 2021
[Interventional endoscopy in hepatico-pancreatico-biliary disease]Emanuel Burri, Christian Ansprenger
Clinical Immunology (Orlando, Fla.)|May 29, 2020
Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DC<sub>leu</sub>)Christian Ansprenger, Daniel Christoph Amberger, Helga Maria Schmetzer
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2014
Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cellsValentin Vogt, Julia Schick, Christian Ansprenger, et al.
Cellular Immunology|March 28, 2018
Paramunity-inducing Factors (PINDs) in dendritic cell (DC) cultures lead to impaired antileukemic functionality of DC-stimulated T-cellsChristian Ansprenger, Valentin Vogt, Julia Schick, et al.
Cellular Immunology|July 29, 2010
Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potentialAnja Liepert, Christine Grabrucker, Andreas Kremser, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2019
Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic ReactionsAnnika Hirn Lopez, Diana Deen, Zuzanna Fischer, et al.
Cancers|March 14, 2026
Modulation of Leukemic Blasts into Dendritic Cells (DC<sub>leu</sub>) and Their Role in Predicting Survival in Patients with AML and MDSDaniel Christoph Amberger, Zuzana Fischer, Diana Deen, et al.
Pageof 1